APA (7th ed.) Citation

Jabir, R. S., Gwo, F. H., Ahmad Annuar, M. A., & Stanslas, J. (2018). Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients. Taylor & Francis.

Chicago Style (17th ed.) Citation

Jabir, Rafid Salim, Fuang Ho Gwo, Muhammad Azrif Ahmad Annuar, and Johnson Stanslas. Plasma Alpha-1-acid Glycoprotein as a Potential Predictive Biomarker for Non-haematological Adverse Events of Docetaxel in Breast Cancer Patients. Taylor & Francis, 2018.

MLA (9th ed.) Citation

Jabir, Rafid Salim, et al. Plasma Alpha-1-acid Glycoprotein as a Potential Predictive Biomarker for Non-haematological Adverse Events of Docetaxel in Breast Cancer Patients. Taylor & Francis, 2018.